Live Accenture Plc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

25076
1
Broad Street Realty, Inc. Broad Street Realty Reports $14.8 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25077
1
Cantor Equity Partners, Inc. Cantor Equity Partners Reports $1.54M Net Income After IPO, Sees Turnaround from Previous Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

25078
1
Silo Pharma, Inc. Silo Pharma Reports $4.39 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25079
1
QUAINT OAK BANCORP INC Quaint Oak Bancorp Reports $685.2 Million in Total Assets and Decline in Net Income for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25080
1
Sphere 3D Corp. Sphere 3D Corp. Reports $16.6 Million Revenue Decline and $9.5 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25081
1
Gulf Coast Ultra Deep Royalty Trust Gulf Coast Ultra Deep Royalty Trust Reports No Distributable Income for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25082
1
Boxlight Corp Boxlight Corporation Reports 23.1% Revenue Decline for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25083
1
GP-Act III Acquisition Corp. GP-Act III Acquisition Corp. Reports $8.67M Net Income for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25084
1
Fold Holdings, Inc. FTAC Emerald Acquisition Corp. Reports $1.87 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25085
1
Hoth Therapeutics, Inc. Hoth Therapeutics Reports $8.2 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25086
1
IMPACT BIOMEDICAL INC. Impact Biomedical Inc. Reports $24.77 Million Net Loss in 2024 Fiscal Year

Via official filing (AI summary) | about 1 year ago | 0 comments

25087
1
NU RIDE INC. Nu Ride Inc. Reports No Revenue for 2024 Following Bankruptcy, Sees Improved Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

25088
1
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics Reports Financial Performance and Strategic Developments for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25089
1
STRATUS PROPERTIES INC Stratus Properties Reports $54.2 Million Revenue and $2 Million Net Income for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25090
1
NATIONAL BANKSHARES INC National Bankshares Reports 51.4% Decrease in Net Income for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25091
1
Hongchang International Co., Ltd Hongchang International Reports Revenue Growth to $2.87 Million Despite Increased Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

25092
1
Entera Bio Ltd. Entera Bio Reports $9.5 Million Net Loss for Fiscal Year 2024, Revenue Increases to $181,000

Via official filing (AI summary) | about 1 year ago | 0 comments

25093
1
Investview, Inc. Investview Reports 23% Revenue Decline for Fiscal Year Ending December 31, 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25094
1
IMMUCELL CORP /DE/ ImmuCell Corporation Reports 52% Increase in Product Sales for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25095
1
Beachbody Company, Inc. Beachbody Reports $418.8 Million Revenue Decline and Strategic Shift to Affiliate Model

Via official filing (AI summary) | about 1 year ago | 0 comments

25096
1
LAVA Therapeutics NV LAVA Therapeutics Reports $25.1 Million Net Loss and Revenue Growth to $12.0 Million for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25097
1
Medicus Pharma Ltd. Medicus Pharma Reports $11.2 Million Net Loss and Significant R&D Investment in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25098
1
GENELUX Corp Genelux Corp. Reports $29.9 Million Net Loss for 2024 Amid Decreased Revenue

Via official filing (AI summary) | about 1 year ago | 0 comments

25099
1
Peraso Inc. Peraso Inc. Reports $14.2 Million Revenue for Fiscal Year 2024, Net Loss Decreases to $10.7 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

25100
1
BioXcel Therapeutics, Inc. BioXcel Therapeutics Reports $59.6M Net Loss and Increased Revenue in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments